Cargando…
Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds
BACKGROUND: Hyperlipidemia is a major component of metabolic syndrome, and often predicts cardiovascular diseases. We developed a new therapeutic agent berberine compounds (BC), consisting of berberine, oryzanol and vitamin B(6), and determined their anti-hyperlipidemia activity and underlying mecha...
Autores principales: | Li, Meng, Shu, Xiangbing, Xu, Hanchen, Zhang, Chunlei, Yang, Lili, Zhang, Li, Ji, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975912/ https://www.ncbi.nlm.nih.gov/pubmed/27495782 http://dx.doi.org/10.1186/s12967-016-0987-5 |
Ejemplares similares
-
Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021) -
Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
por: Li, Xiao-Yang, et al.
Publicado: (2015) -
Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats
por: Zhou, Peipei, et al.
Publicado: (2019) -
The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet
por: Zhang, Qing, et al.
Publicado: (2020) -
Study on the protective effect of berberine treatment on sepsis based on gut microbiota and metabolomic analysis
por: Pan, Huibin, et al.
Publicado: (2022)